[Comment] RELIEVE UCCD: one pathway, two diseases, and a glimpse into the future of IBD trial design | ClinicLens
The development of new therapies for inflammatory bowel disease (IBD) has traditionally followed a familiar path: ulcerative colitis and Crohn's disease are studied separately, under separate protocols, with separate development programmes and separate timelines. Yet, clinic
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.